You are here: Industry Insights > Peptide

News List

Famous GLP-1RA Outside of the Circle, and Rapid Development of Peptide CDMO Xiaobin/PharmaSources
August 07, 2023
With the famous weight-loss drugs are famous outside of the circle, such as GLP-1RA, it has also stimulated the market's demand and concern for peptide CDMO.
CordenPharma Collaborates with PeptiSystems contractpharma
January 18, 2022
Partner on continuous peptide manufacturing and green chemistry.
Press Release Protagonist Therapeutics Announces the Selection of Oral Peptide PN-235 into Phase 2 Clinical Development Program for Multiple Indications FirstWordPharma
December 03, 2021
Protagonist Therapeutics (Nasdaq: PTGX) ("Protagonist" or "the Company") today announced the selection of PN-235 (JNJ-77242113) as the final candidate for all clinical studies in multiple indications based on intervention of the Interleukin-23 (IL-23)...
Intranasal anti-depressant drug successfully delivered to the brain EuropeanPharmaceuticalReview
November 15, 2021
A team of researchers at the Tokyo University of Science (TUS), Japan, have achieved success in the intranasal delivery of the anti-depressant drug glucagon-like peptide 2 (GLP-2) in a mouse model of depression.
Introducing Prodigy for Improved Peptide Purification prnasia
October 27, 2021
CEM Corporation is proud to announce the release of the new Prodigy™ Preparative High-Performance Liquid Chromatography (HPLC) system. Key to the system is its unique elevated temperature capability...
Orbit Discovery raises $7.6m to boost peptide drug discovery services pharmatimes
July 22, 2021
Oxford, UK-based Orbit Discoveries has raised $7.6m in funding to boost its peptide drug discovery services and accelerate the growth of its business.
RegeneRx Biopharmaceuticals Announces $2 Million Private Placement firstwordpharma
June 29, 2021
RegeneRx Biopharmaceu today announced that it has entered into a definitive agreement with certain institutional and accredited investors, including certain directors and officers of the Company, in connection with a private placement of up to $2,000,000.
CordenPharma Colorado Continues Expansion contractpharma
May 14, 2021
In the fourth quarter of 2020 CordenPharma announced both an expansion of non-GMP capacity at its Center of Excellence for Peptide Process Development in Frankfurt, Germany, and a major increase in upstream capacity with the introduction of a new ...
ISSAR Pharma announces out-licensing of its peptide-based NCEs expresspharma
April 21, 2021
ISSAR has several patents for peptide molecules lined up in their development pipeline targeting therapeutic areas such as oncology, dermatology, gastroenterology and diseases of bones and joints.
CordenPharma Colorado Increases US Peptide Manufacturing Capacity contractpharma
November 26, 2020
Long-term expansion initiative approved to further increase flexibility, efficiency and ultimately, cost-effective production.

Previous page 1 2 Next page